Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

Sun Pharma has made its play just three months after Checkpoint won FDA approval for PD-L1 inhibitor Unloxcyt (cosibelimab) ...

The agreement was signed in a letter of intent March 3 to set the groundwork for whether government health programs in ...

In a small study in a community oncology practice, more than 60% of patients with advanced squamous cell skin cancer treated ...

Libtayo received positive phase 3 trial results in high-risk adjuvant cutaneous squamous cell carcinoma (CSCC). Regeneron reported Q4 2024 EPS of $12.07, beating consensus estimates by 71 cents.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Glycolic acid is a substance that chemically exfoliates a person’s skin by dissolving dead skin cells and oils. Glycolic acid may also help boost collagen production, and support skin moisture.

The THIO-101 study in 3L will enroll up to 48 patients with two arms: Arm 1, continuing the evaluation of THIO sequenced with Libtayo ® (cemiplimab); and Arm 2, evaluating THIO as a monotherapy, to ...

Cutaneous candidiasis is a yeast infection that affects the skin and causes a red rash accompanied by dry and scaly patches of skin. Sometimes, these scales will ooze pus or become crusty. Although ...

Skin cancers come in all shapes and sizes, but when it comes to identifying Basal cell carcinoma, squamous cell carcinoma and melanoma, here are a few key signs to look out for: Did you read?